{"id":"W2026003958","doi":"10.1182/blood-2013-08-523845","title":"Phase 2 study of VcR-CVAD with maintenance rituximab for untreated mantle cell lymphoma: an Eastern Cooperative Oncology Group study (E1405)","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Medicine; Mantle cell lymphoma; Vincristine; Bortezomib; Rituximab; Internal medicine; Autologous stem-cell transplantation; Progression-free survival; Surgery; Chemoimmunotherapy; Cyclophosphamide; Oncology; Lymphoma; Chemotherapy; Multiple myeloma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004638263,0.001455841,0.001936251,0.0006141441,0.0003971194,0.001058281,0.001393409,0.001638936,0.002794035],"category_scores_gemma":[0.001365566,0.0007846042,0.001329642,0.0005407626,0.000998723,0.0008067994,0.0005373089,0.002400474,0.0005541584],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001207758,"about_ca_system_score_gemma":0.002338521,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001550701,"about_ca_topic_score_gemma":0.002660132,"domain_scores_codex":[0.9986077,0.0008830983,0.00006420632,0.0001634323,0.000112924,0.0001686736],"domain_scores_gemma":[0.999036,0.0001694404,0.0001866886,0.0001093649,0.00006509423,0.0004334129],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7888762,0.1199381,0.006211616,0.0005169112,0.00137458,0.0001921283,0.0003015006,0.00146008,0.02471554,0.0002729265,0.001570205,0.05457019],"study_design_scores_gemma":[0.6399773,0.3493167,0.006995809,0.00001977615,0.000310531,0.00009620462,0.00002825531,0.0004709921,0.00154503,0.00007466907,0.00114962,0.00001507656],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933537,0.001008671,0.0003978305,0.0001551288,0.0000498456,0.003598548,0.0005265638,0.00005460316,0.0008551397],"genre_scores_gemma":[0.9852338,0.001079491,0.002710207,0.0008079497,0.0001706714,0.005887887,0.002352639,0.00002711799,0.001730161],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004638263,"threshold_uncertainty_score":0.02452981,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01799034897380513,"score_gpt":0.2984835278271166,"score_spread":0.2804931788533114,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}